KOL Breakfast, Mon, Dec 2nd, hosted by Protalix (PLX)

The meeting will feature a presentation from Key Opinion Leader (KOL) David G. Warnock, MD (University of Alabama at Birmingham) who will discuss the current treatment landscape as well as the unmet medical need for treating patients with Fabry disease. Dr. Warnock will be available to answer questions at the conclusion of the event.